Send feedback

EFEMP2 p.Val87Ile

c.259G>A · rs149525720 · VCV650013

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 7 submitters
AlphaMissense
likely benign
0.1265 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0801%, afr)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
2
Cardiovascular phenotype

Computational evidence

Protein change
AlphaMissense0.1265likely benign
REVEL0.336indeterminate
SaProtLLR -6.44tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 4.8GERP 1.7, phastCons 1
Regional constrainto/e 0.83unconstrained · MANE · 5,433 bp · p 3.8e-05 · regional, not allelic
Overall
CADD20.4PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0801% African / African-American · 60/74,920 alleles
Filtering AF 0.0638% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.058%
Overall 0.0116% 187/1,613,912 alleles · ultra-rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.196% 510
African / African-Americangrpmax 0.0801% 1,249
South Asian 0.0307% 3,253
Admixed American 0.0167% 6,000
Middle Eastern 0.0164% 6,082
Remaining individualsnot grpmax-eligible 0.0128% 7,811
East Asian 0.00223% 44,894
European (non-Finnish) 0.0017% 58,995
Finnishnot grpmax-eligible 0.00156% 64,036

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
EFEMP2
Protein
p.Val87Ile
Coding
c.259G>A
MANE Select
NM_016938
dbSNP
rs149525720
Type
single nucleotide variant
Location
chr11:65871265 (GRCh38)
Gene constraint
LOEUF 0.56 · pLI 0.62 (gnomAD)
Structure
AlphaFold pLDDT 82.95 · 1 PDB
Residue 87
a disulfide bond; a functional site (cleavage; by elane)
Full EFEMP2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/efemp2-p-val87ile (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown